Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jul 23, 2015
Tools & Techniques
Gene therapy's coming of age
...GenVec Inc. , Milo Biotechnology LLC , Momotaro-Gene Inc. , MultiVir Inc. , Novartis,
PNP Therapeutics Inc.
...
Read More
BioCentury
|
Dec 9, 2013
Clinical News
AD/PNP-FaraAMP: Phase I ongoing
...of adenovirus plus the 75 mg/m 2 dose of fludarabine in the same dosing schedule.
PNP Therapeutics Inc.
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Jul 23, 2015
Tools & Techniques
Gene therapy's coming of age
...GenVec Inc. , Milo Biotechnology LLC , Momotaro-Gene Inc. , MultiVir Inc. , Novartis,
PNP Therapeutics Inc.
...
Read More
BioCentury
|
Dec 9, 2013
Clinical News
AD/PNP-FaraAMP: Phase I ongoing
...of adenovirus plus the 75 mg/m 2 dose of fludarabine in the same dosing schedule.
PNP Therapeutics Inc.
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page